Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2006-07-18
Product name
Equilibration Solution; part of "DeStreak Starter
supplier name
GE Healthcare UK Ltd
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
This material is considered hazardous by the OSHA Hazard Communication Standard ( 29 CFR 1910. 1200 ) Physical state Liquid. Odor Odorless. OSHA/HCS status This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview WARNING! HARMFUL IF SWALLOWED. CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. MAY BE HARMFUL IF ABSORBED THROUGH SKIN. CONTAINS MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE. Harmful if swallowed. May be harmful if absorbed through skin. Irritating to eyes, respiratory system and skin. Do not breathe vapor or mist. Do not ingest. Do not get in eyes. Avoid contact with skin and clothing. Contains material that can cause target organ damage. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use. Wash thoroughly after handling. Routes of entry Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Eyes Irritating to eyes. Skin Harmful in contact with skin. Irritating to skin. Inhalation Irritating to respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion Toxic if swallowed.
Potential chronic health
effects Contains material that can cause target organ damage. Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which may cause damage to the following organs: kidneys, upper respiratory tract, skin, eye, lens or cornea. Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specific data. Skin Adverse symptoms may include the following: irritation redness Eyes Adverse symptoms may include the following: pain or irritation watering redness
Medical Conditions Generally Aggravated by Exposure
Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be over-exposure aggravated by over-exposure to this product. See toxicological information (section 11)
